Lixisenatide Attenuates Advanced Glycation End Products (AGEs)-induced Degradation of Extracellular Matrix in Human Primary Chondrocytes
Artificial Cells, Nanomedicine and Biotechnology - United States
doi 10.1080/21691401.2019.1593996
Full Text
Open PDFAbstract
Available in full text
Date
April 3, 2019
Authors
Publisher
Informa UK Limited